Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies
Iosif Papafragkos, Efrosyni Markaki, Christina Kalpadakis, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3462-3462
Open Access | Times Cited: 12

Showing 12 citing articles:

Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
Shifen Wang, Xingyun Zhao, Siwen Wu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 26
Ablation of NLRP3 inflammasome rewires MDSC function and promotes tumor regression
Iosif Papafragkos, Maria Grigoriou, Louis Boon, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Myeloid-derived suppressor cells exhibit distinct characteristics in bone marrow and blood of individuals with diffuse large B-cell lymphoma
Paris Efstratiou, Athina Damianaki, Aglaia Kavidopoulou, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Myeloid-Derived Suppressor Cells and Macrophage Polarization in Cancer Immunotherapy
Mohammad‐Salar Hosseini, Mohammad Amin Akbarzadeh, Farhad Jadidi‐Niaragh
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 157-204
Closed Access | Times Cited: 2
The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome
Denis Miyashiro, Bruno de Castro e Souza, Marina Passos Torrealba, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 936-936
Open Access | Times Cited: 11
New Perspectives on Myeloid-Derived Suppressor Cells and Their Emerging Role in Haematology
Nikoleta Bizymi, Andreas Μ. Matthaiou, Angelos Matheakakis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5326-5326
Open Access | Times Cited: 11
The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers
Rong Fan, Nathan De Beule, Anke Maes, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Skin repair and immunoregulatory effects of myeloid suppressor cells from human cord blood in atopic dermatitis
Chang‐Hyun Kim, Seung-Min Hong, Sueon Kim, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 1
Accumulation of circulating myeloid-derived suppressor cell subsets: predicting poor clinical efficacy and prognosis through T cell suppression in non-Hodgkin's lymphoma
Lianfang Pu, Manman Li, Xiangjiang Feng, et al.
Journal of Leukocyte Biology (2024) Vol. 115, Iss. 6, pp. 1094-1107
Closed Access | Times Cited: 1
PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis
Athina Boumpas, Antonis Papaioannou, Pavlos Bousounis, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Myeloid-Derived Suppressor Cells (MDSCs) in Haematology
Nikoleta Bizymi, Helen Α. Papadaki
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 187-187
Open Access | Times Cited: 3
C3d(g), iron nanoparticles, hemin and cytochrome c may induce oxidative cytotoxicity in tumors and reduce tumor-associated myeloid cells-mediated immunosuppression
Efstathios Kavvadas
Medical Hypotheses (2022) Vol. 167, pp. 110944-110944
Open Access
Page 1

Scroll to top